Last Update Time:
22-Jan-2025 16:00:00
ISIN:
INE089A01031
Sector:
Healthcare
Symbol:
DRREDDY
Dr. Reddy's Laboratories Limited
₹1,296.00
₹7.85
(0.61%)
▲
Prev. Close
₹1,288.15
Open
₹1,291.00
Close
₹1,296.25
High
₹1,308.00
Low
₹1,288.00
Ind. Close
₹0.00
VWAP
₹1,297.57
Price Chart
Pre Open Market Overview: 22-Jan-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1291
- Previous Close Price: 1288.15
- Change: 2.85%
- Total Traded Volume: 773
- Total Buy Quantity: 6,061
- Total Sell Quantity: 13,866
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,288.90 | 1.00 | 0.00 |
| 1,289.00 | 5.00 | 0.00 |
| 1,290.00 | 2.00 | 0.00 |
| 1,290.10 | 8.00 | 0.00 |
| 1,291.00 | 25.00 | 0.00 |
| 1,291.80 | 0.00 | 1.00 |
| 1,295.00 | 0.00 | 80.00 |
| 1,295.90 | 0.00 | 1.00 |
| 1,296.00 | 0.00 | 1.00 |
| 1,296.10 | 0.00 | 27.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 0
Total Sell Quantity: 0
Shareholding Patterns (in %)
| Category | 31-Dec-2023 | 31-Mar-2024 | 30-Jun-2024 | 30-Sep-2024 | 31-Dec-2024 |
|---|---|---|---|---|---|
| Promoter & Promoter Group | 26.65 | 26.65 | 26.65 | 26.64 | 26.64 |
| Public | 73.17 | 73.17 | 73.18 | 73.20 | 73.20 |
| Shares held by Employee Trusts | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Key Trade Statistics
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 13.01 |
| Traded Value (₹ Cr.) | 168.87 |
| Total Market Cap (₹ Cr.) | 108,141.35 |
| Free Float Market Cap (₹ Cr.) | 78,942.10 |
| Impact cost | 0.02 |
| Quantity Traded | 1,301,422.00 |
| Deliverable Quantity | 574,673.00 |
| % of Quantity to Traded | 44.16 |
| Security VaR | 7.85 |
| Index VaR | N/A |
| VaR Margin | 9 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 12.5 |
| Face Value | 1 |
Key Price Statistics
| Price Information | Details |
|---|---|
| 52 Week High (21-Aug-2024) | 1,421.49 |
| 52 Week Low (04-Jun-2024) | 1,120.00 |
| Upper Band | 1,416.95 |
| Lower Band | 1,159.35 |
| Price Band (%) | No Band |
| Daily Volatility | 1.26 |
| Annualised Volatility | 24.07 |
| Tick Size | 0.05 |
Key Securities Statistics
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 30-May-2003 |
| Adjusted P/E | 19.88 |
| Symbol P/E | 19.88 |
| Index | NIFTY 50 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements
| Subject | Date |
|---|---|
| General Updates | 22-Jan-2025 |
| General Updates | 09-Jan-2025 |
| Sale or disposal-XBRL | 08-Jan-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 08-Jan-2025 |
| General Updates | 07-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 03-Jan-2025 |
| Credit Rating | 27-Dec-2024 |
| Incorporation-XBRL | 24-Dec-2024 |
Corporate Actions
| Face Value | Purpose | Ex-Date | BC Start DateStart Date | BC End Date |
|---|---|---|---|---|
| 1 | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share | 28-Oct-2024 | - | - |
| 1 | Annual General Meeting/Dividend - Rs 40 Per Share | 16-Jul-2024 | 17-Jul-2024 | 19-Jul-2024 |
| 1 | Annual General Meeting/Dividend - Rs 40 Per Share | 11-Jul-2023 | 12-Jul-2023 | 14-Jul-2023 |
| 1 | Annual General Meeting/Dividend - Rs 30 Per Share | 11-Jul-2022 | 13-Jul-2022 | 15-Jul-2022 |
| 1 | Annual General Meeting/Dividend - Rs 25 Per Share | 09-Jul-2021 | 13-Jul-2021 | 15-Jul-2021 |
| 1 | Annual General Meeting/Dividend - Rs 25 Per Share | 13-Jul-2020 | 15-Jul-2020 | 17-Jul-2020 |
| 1 | Annual General Meeting/Dividend - Rs 20 Per Share | 15-Jul-2019 | 17-Jul-2019 | 19-Jul-2019 |
| 1 | Annual General Meeting/Dividend- Rs 20 Per Share | 16-Jul-2018 | 18-Jul-2018 | 20-Jul-2018 |
| 1 | Annual General Meeting/Dividend - Rs 20/- Per Share | 17-Jul-2017 | 19-Jul-2017 | 21-Jul-2017 |
| 1 | Annual General Meeting/ Dividend - Rs 20/- Per Share | 18-Jul-2016 | 20-Jul-2016 | 22-Jul-2016 |
| 1 | Annual General Meeting/Dividend Rs 20/- Per Share | 10-Jul-2015 | 14-Jul-2015 | 17-Jul-2015 |
| 1 | Annual General Meeting / Final Dividend - Rs 18/- Per Share | 11-Jul-2014 | 15-Jul-2014 | 18-Jul-2014 |
| 1 | Annual General Meeting And Dividend Rs.15/- Per Share | 12-Jul-2013 | 16-Jul-2013 | 19-Jul-2013 |
| 1 | Annual General Meeting And Dividend - Rs.13.75 Per Share | 28-Jun-2012 | 03-Jul-2012 | 06-Jul-2012 |
| 1 | Annual General Meeting And Dividend Rs.11.25 Per Share | 30-Jun-2011 | 05-Jul-2011 | 09-Jul-2011 |
| 1 | Scheme Of Arrangement - Bonus Debentures 6:1 | 17-Mar-2011 | - | - |
| 1 | Annual General Meeting And Final Dividend Rs.11.25 Per Share | 02-Jul-2010 | 06-Jul-2010 | 10-Jul-2010 |
| 1 | Agm/Div-Rs.6.25 Per Share | 03-Jul-2009 | 07-Jul-2009 | 11-Jul-2009 |
| 1 | Agm/Dividend - 75% | 04-Jul-2008 | 08-Jul-2008 | 12-Jul-2008 |
| 1 | Dividend-75% | 06-Jul-2007 | 10-Jul-2007 | 14-Jul-2007 |
Board Meetings
Financial Results
Company Directory
| Web Address | SM Name | Office | Address | City | Pincode | Telephone | |
|---|---|---|---|---|---|---|---|
| www.drreddys.com | Dr. Reddy's Laboratories Limited | Registered Office | 8-2-337,Road No.3,<br>Banjara Hills,<br> | HYDERABAD | 500034 | 040-040-49002900 | shares@drreddys.com |
| www.drreddys.com | Dr. Reddy's Laboratories Limited | Transfer Agent | Bigshare Services Pvt. Ltd.<br>306, Right Wing, 3rd Floor,Amrutha Ville,<br>Opp. Yashodha Hospital,<br>Rajbhavan Road, Somajiguda, | HYDERABAD | 500082 | 040-23374967 | bsshyd@bigshareonline.com |
Insider Trading
| Reg. Clause | Acq./Disp. | Sec. (No.) | Sec. Value | Txn Type | Bcast Time |
|---|---|---|---|---|---|
| 7(2) | Anjum Swaroop | 1412 | 9252836 | Buy | 26-Sep-2024 14:51 |
| 7(2) | C Swaminathan | 1700 | 11307403 | Sell | 26-Sep-2024 14:51 |
| 7(2) | Vincent Colicchio | 1594 | 10445482 | Buy | 26-Sep-2024 14:51 |
| 7(2) | Subba Inta | 704 | 4867456 | Buy | 04-Sep-2024 15:47 |
| 7(2) | Juan Carlos Alvarez | 145 | 1002530 | Buy | 04-Sep-2024 15:47 |
| 7(2) | Sanjay Choubey | 215 | 1486510 | Buy | 04-Sep-2024 15:47 |
| 7(2) | Tricia Wetzel | 594 | 4040850 | Buy | 04-Sep-2024 15:47 |
| 7(2) | C Swaminathan | 1250 | 8643406 | Buy | 04-Sep-2024 15:47 |
| 7(2) | Jeff Jorgenson | 474 | 3277236 | Buy | 04-Sep-2024 15:47 |
| 7(2) | Bryan Dixon | 150 | 1037100 | Buy | 04-Sep-2024 15:47 |
| 7(2) | Milan Kalawadia | 814 | 5627996 | Buy | 04-Sep-2024 15:47 |
| 7(2) | EREZ ISRAELI | 27635 | 445884700 | Buy | 07-Aug-2024 18:44 |
| 7(2) | EREZ ISRAELI | 65500 | 439598403 | Sell | 07-Aug-2024 18:44 |
| 7(2) | Sonal Shah | 136 | 828934 | Buy | 20-Jun-2024 19:01 |
| 7(2) | C Swaminathan | 625 | 3809438 | Buy | 20-Jun-2024 19:01 |
| 7(2) | Tricia N Wetzel | 1550 | 9763760 | Buy | 19-Mar-2024 21:29 |
| 7(2) | Keerthi Kandlikar | 80 | 503936 | Buy | 19-Mar-2024 21:29 |
| 7(2) | Jaya Lakshmi Ayyagari | 503 | 3168497 | Buy | 19-Mar-2024 21:29 |
| 7(2) | John Roosenberg II | 175 | 1102220 | Buy | 26-Feb-2024 19:05 |
| 7(2) | Uragasainareddy Medapati | 160 | 1007744 | Buy | 26-Feb-2024 19:05 |
Annual Reports
Investor Complaints
| Date | Pending | Received | Disposed | Unresolved |
|---|---|---|---|---|
| 31-Dec-2024 | 0 | 3 | 3 | 0 |
| 31-Dec-2024 | 0 | 3 | 3 | 0 |
| 30-Sep-2024 | 0 | 0 | 0 | 0 |
| 30-Jun-2024 | 0 | 2 | 2 | 0 |
| 31-Mar-2024 | 0 | 1 | 1 | 0 |
| 31-Dec-2023 | 0 | 2 | 2 | 0 |
| 30-Sep-2023 | 0 | 5 | 5 | 0 |
| 30-Jun-2023 | 0 | 2 | 2 | 0 |
| 31-Mar-2023 | 0 | 3 | 3 | 0 |
| 31-Dec-2022 | 1 | 0 | 1 | 0 |
| 30-Sep-2022 | 0 | 5 | 4 | 1 |
| 30-Jun-2022 | 0 | 0 | 0 | 0 |
| 31-Mar-2022 | 0 | 1 | 1 | 0 |
| 31-Dec-2021 | 0 | 1 | 1 | 0 |
| 30-Sep-2021 | 0 | 1 | 1 | 0 |
| 30-Jun-2021 | 0 | 4 | 4 | 0 |
| 31-Mar-2021 | 0 | 3 | 3 | 0 |
| 31-Dec-2020 | 0 | 1 | 1 | 0 |
| 30-Sep-2020 | 0 | 3 | 3 | 0 |
| 30-Jun-2020 | 0 | 0 | 0 | 0 |
| 31-Mar-2020 | 0 | 1 | 1 | 0 |
| 31-Dec-2019 | 0 | 1 | 1 | 0 |
| 30-Sep-2019 | 0 | 1 | 1 | 0 |
| 30-Jun-2019 | 0 | 6 | 6 | 0 |
| 31-Mar-2019 | 0 | 2 | 2 | 0 |
| 31-Dec-2018 | 0 | 6 | 6 | 0 |
| 30-Sep-2018 | 0 | 1 | 1 | 0 |
| 30-Jun-2018 | 0 | 3 | 3 | 0 |
| 31-Mar-2018 | 0 | 4 | 4 | 0 |
| 31-Dec-2017 | 0 | 3 | 3 | 0 |
| 30-Sep-2017 | 0 | 3 | 3 | 0 |
| 30-Jun-2017 | 0 | 2 | 2 | 0 |
| 31-Mar-2017 | 0 | 3 | 3 | 0 |
| 31-Dec-2016 | 0 | 4 | 4 | 0 |
| 30-Sep-2016 | 0 | 3 | 3 | 0 |
| 31-Mar-2016 | 0 | 7 | 7 | 0 |
| 31-Dec-2015 | 0 | 3 | 3 | 0 |
Event Calendar
| Company | Purpose | Details | Date |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2011 and recommend dividend, if any, for the financial year 2010-11. | 13-May-2011 |
| Dr. Reddy's Laboratories Limited | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012 and recommend dividend, if any, for the financial year 2011-12. | 11-May-2012 |
| Dr. Reddy's Laboratories Limited | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2013 and recommend dividend, if any, for the financial year 2012-13. | 14-May-2013 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30. 2013. | 30-Jul-2013 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2013. | 31-Oct-2013 |
| Dr. Reddy's Laboratories Limited | Results | to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2013. | 11-Feb-2014 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2013. | 11-Feb-2014 |
| Dr. Reddy's Laboratories Limited | Results | interalia,to consider the Audited Financial results for the financial year 2013-14 | 13-May-2014 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30. 2014. | 30-Jul-2014 |
| Dr. Reddy's Laboratories Limited | Results | Inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2014. | 29-Oct-2014 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2014. | 29-Jan-2015 |
| Dr. Reddy's Laboratories Limited | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2015 and recommend dividend, if any, for the financial year 2014-15. | 12-May-2015 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2015. | 30-Jul-2015 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended September 30, 2015. | 29-Oct-2015 |
| Dr. Reddy's Laboratories Limited | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2015. | 09-Feb-2016 |
| Dr. Reddy's Laboratories Limited | Buyback | To consider the buyback of equity shares of the Company and other allied matters, as appropriate. | 17-Feb-2016 |
| Dr. Reddy's Laboratories Limited | Results/Dividend | inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2016 and recommend dividend, if any, for the financial year 2015-16. | 12-May-2016 |
| Dr. Reddy's Laboratories Limited | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2016. | 26-Jul-2016 |
| Dr. Reddy's Laboratories Limited | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016. | 25-Oct-2016 |
| Dr. Reddy's Laboratories Limited | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016. | 04-Feb-2017 |
| Dr. Reddy's Laboratories Limited | Results/Dividend | inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2017 and recommend dividend, if any, for the financial year 2016-17. Further, that the Company s trading window for dealing in securities by the Insiders is closed from April 26, 2017 and ending on May 14, 2017 (both days inclusive). | 12-May-2017 |
| Dr. Reddy's Laboratories Limited | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. | 27-Jul-2017 |
| Dr. Reddy's Laboratories Limited | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2017. | 31-Oct-2017 |
| Dr. Reddy's Laboratories Limited | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2017. | 25-Jan-2018 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend | 22-May-2018 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | 26-Jul-2018 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | 26-Oct-2018 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the unaudited financial results for the period ended December 31, 2018 | 01-Feb-2019 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend | 17-May-2019 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 | 29-Jul-2019 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the unaudited financial results for the period ended September 30, 2019 | 01-Nov-2019 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended December 31, 2019 | 27-Jan-2020 |
| Dr. Reddy's Laboratories Limited | Fund Raising | To consider fund raising through issuance of Commercial Papers | 27-Mar-2020 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | DRREDDY : 20-May-2020 : The Company has informed the Exchange that a Board meeting to be held on May 13, 2020 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 20, 2020, To consider and approve the financial results for the period ended March 31, 2020 and dividend | 13-May-2020 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend | 13-May-2020 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 | 29-Jul-2020 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the unaudited financial results for the quarter and half-year ended ended September 30, 2020 | 28-Oct-2020 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended December 31, 2020 | 29-Jan-2021 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | To consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2021, and recommend dividend, if any, for the financial year 2020-21. | 14-May-2021 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 | 27-Jul-2021 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended September 30, 2021 | 29-Oct-2021 |
| Dr. Reddy's Laboratories Limited | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters | 28-Jan-2022 |
| Dr. Reddy's Laboratories Limited | Financial results | Dr. Reddy's Laboratories Limited has informed the Exchange about Board Meeting scheduled to be held on July 28, 2022, to consider and approve the Unaudited Financial Results of the Company for the quarter ending on June 30, 2022. | 28-Jul-2022 |
| Dr. Reddy's Laboratories Limited | Financial results | Dr. Reddy's Laboratories Limited has informed the Exchange that a meeting of the Board of Directors of the Company will be held on Friday, October 28, 2022, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ending on September 30, 2022. | 28-Oct-2022 |
| Dr. Reddy's Laboratories Limited | Financial Results | To inter-alia consider and approve the unaudited financial results for the quarter and nine months ending December 31, 2022 | 25-Jan-2023 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on March 31, 2023, and to recommend dividend, if any, for the financial year 2022-23. | 10-May-2023 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the unaudited financial results for the quarter ending Jun 30, 2023 | 26-Jul-2023 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the unaudited financial results for the quarter and half year ending September 30, 2023 | 27-Oct-2023 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the unaudited financial results for the quarter and nine months ending December 31, 2023 | 30-Jan-2024 |
| Dr. Reddy's Laboratories Limited | Financial Results/Dividend | To consider and approve the Audited Standalone and Consolidated financial results for quarter and financial year ending on March 31, 2024, and to recommend dividend, if any, for the financial year 2023-24 | 07-May-2024 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the Unaudited financial results for the quarter ending June 30, 2024 | 27-Jul-2024 |
| Dr. Reddy's Laboratories Limited | Stock Split | To consider stock split of equity shares | 27-Jul-2024 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 | 05-Nov-2024 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 | 05-Nov-2024 |
| Dr. Reddy's Laboratories Limited | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 | 23-Jan-2025 |
Share Transfers
Voting Results
| Date of Mtg. | Mtg. Type | Resolution | R. required | Total SHs | % favour | % against | Att. |
|---|---|---|---|---|---|---|---|
| 12-SEP-2024 | Postal Ballot | Approval of sub-division/split of each equity share of Rs. 5/- (Rupees five only) each into 5 (five) equity shares of Re. 1/- (Rupee one only) each and consequent alteration to the Memorandum of Association of the Company | Ordinary | 284425 | 99.88 | 0.12 | No File Available |
| 29-JUL-2024 | AGM | Adoption of the financial statements (standalone and consolidated) of the Company for the year ended March 31,2024, together with reports of the Board of Directors and Auditors thereon | Ordinary | 271732 | 99.9 | 0.1 | No File Available |
| 29-JUL-2024 | AGM | Remuneration payable to Cost Auditors, M/s.Sagar & Associates,Cost Accountants, for the financial year ending March 31,2025 | Ordinary | 271732 | 100 | 0 | No File Available |
| 29-JUL-2024 | AGM | Appointment of Mr. Vishal Reddy, a related party, as an entry level employee in Dr. Reddy￢ﾀﾙs Laboratories Inc, USA, a wholly owned subsidiary of the Company | Ordinary | 271732 | 99.98 | 0.02 | No File Available |
| 29-JUL-2024 | AGM | Re-Appointment of K Satish Reddy (DIN: 00129701), as a Director, who retires by rotation, and being eligible offers himself for re-appointment | Ordinary | 271732 | 95.24 | 4.76 | No File Available |
| 29-JUL-2024 | AGM | Declaration of Dividend of Rs.40 per share for the financial year ended March 31, 2024 | Ordinary | 271732 | 99.92 | 0.08 | No File Available |
| 14-FEB-2024 | Postal Ballot | Approval of the appointment of Mr. Sanjiv Soshil Mehta (DIN: 06699923) as an Independent Director of the Company, in terms of Section 149 of the Companies Act, 2013 | Special | 272623 | 99.76 | 0.24 | No File Available |
| 15-NOV-2023 | Postal Ballot | Approval of appointment of Dr. Alpna Hansraj Seth (DIN: 01183914), as an Independent Director in terms of Section 149 of the Companies Act, 2013 | Special | 254787 | 99.62 | 0.38 | No File Available |
| 27-JUL-2023 | AGM | Adoption of the financial statements(standalone and consolidated)of the Company for the year ended March 31,2023, together with reports of the Board of Directors and Auditors thereon | Ordinary | 246119 | 100 | 0 | No File Available |
| 27-JUL-2023 | AGM | Remuneration payable to Cost Auditors, M/s.Sagar & Associates,Cost Accountants, for the financial year ending March 31,2024 | Special | 246119 | 99.88 | 0.12 | No File Available |
| 27-JUL-2023 | AGM | Re-Appointment of Ms.Shika Sharma (DIN:0043625) as an Independent Director for a second term of five years, in terms of Section 149 of the Companies Act,2013 | Special | 246119 | 97.72 | 2.28 | No File Available |
| 27-JUL-2023 | AGM | Re-Appointment of Mr.Leo puri (DIN:01764813)as an Independent Director for a second term of five years, in terms of Section 149 of the Companies Act,2013 | Special | 246119 | 99.62 | 0.38 | No File Available |
| 27-JUL-2023 | AGM | Appointment of Dr.Claudio Albrecht (DIN:10109819),as an Independent Director of the Company,in terms of Section 149 of the Companies Act,2013 | Special | 246119 | 99.68 | 0.32 | No File Available |
| 27-JUL-2023 | AGM | Re-Appointment of Mr.G.V.Prasad (DIN:00057433),as a Director,who retires by rotation,and being eligible offers himself for re-appointment | Ordinary | 246119 | 99.35 | 0.65 | No File Available |
| 27-JUL-2023 | AGM | Declaration of Dividend of Rs.40 per share for the financial year ended March 31,2023 | Ordinary | 246119 | 99.92 | 0.08 | No File Available |
| 20-OCT-2022 | Postal Ballot | Approval of the appointment of Mr. Arun M Kumar (DIN: 09665138) as an Independent Director in terms of section 149 of the Companies Act,2013 | Special | 268755 | 99.72 | 0.28 | No File Available |
| 29-JUL-2022 | AGM | Adoption of the Financial Statements (Standalone and Consolidated) of the Company for the year ended March 31, 2022, together with the reports of the Board of Directors and Auditors thereon. | Ordinary | 261880 | 99.94 | 0.06 | No File Available |
| 29-JUL-2022 | AGM | Approval of the reappointment of Mr. K Satish Reddy (DIN: 00129701) as a Whole-time Director, designated as Chairman | Ordinary | 261880 | 95.76 | 4.24 | No File Available |
| 29-JUL-2022 | AGM | Reappointment of Mr. K Satish Reddy (DIN: 00129701), as a director, who retires by rotation, and being eligible offers himself for the reappointment | Ordinary | 261880 | 96.31 | 3.69 | No File Available |
| 29-JUL-2022 | AGM | Declaration of dividend of Rs.30 per equity share for the financial year ended March 31, 2022. | Ordinary | 261880 | 100 | 0 | No File Available |